Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.

Lesko LJ, Zineh I.

Pharmacogenomics. 2010 Apr;11(4):507-12. doi: 10.2217/pgs.10.16.

2.

Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.

Zineh I, Pacanowski MA.

Pharmacotherapy. 2011 Aug;31(8):729-35. doi: 10.1592/phco.31.8.729.

PMID:
21923598
3.
4.

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

Trent RJ, Cheong PL, Chua EW, Kennedy MA.

Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e. Review.

PMID:
23594690
5.

Clinical implementation of genetic testing in medicine: a US regulatory science perspective.

Lesko LJ, Schmidt S.

Br J Clin Pharmacol. 2014 Apr;77(4):606-11. doi: 10.1111/bcp.12299.

6.

Drugs, diabetes and pharmacogenomics: the road to personalized therapy.

Watanabe RM.

Pharmacogenomics. 2011 May;12(5):699-701. doi: 10.2217/pgs.11.29. No abstract available.

PMID:
21619432
7.

One size fits one: pharmacogenetics in gastroenterology.

Porayette P, Flockhart D, Gupta SK.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):565-70. doi: 10.1016/j.cgh.2014.01.035. Review.

PMID:
24486737
8.

From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.

Wong SH, Happy C, Blinka D, Gock S, Jentzen JM, Donald Hon J, Coleman H, Jortani SA, Lucire Y, Morris-Kukoski CL, Neuman MG, Orsulak PJ, Sander T, Wagner MA, Wynn JR, Wu AH, Yeo KT.

Pharmacogenomics. 2010 Jun;11(6):731-7. doi: 10.2217/pgs.10.63. No abstract available.

9.

Progress in pharmacogenomics and its promise for medicine.

Blake CA, Sobel BE.

Exp Biol Med (Maywood). 2008 Dec;233(12):1482-3. doi: 10.3181/0806-S-208.

PMID:
18849537
10.

Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.

Alfirevic A, Pirmohamed M.

Pharmacogenomics. 2010 Apr;11(4):497-9. doi: 10.2217/pgs.10.12.

11.

[Pharmacogenomics].

Nakatani K, Nobori T.

Rinsho Byori. 2013 Nov;61(11):1018-25. Review. Japanese.

PMID:
24450107
12.

Pharmacogenetics, pharmacogenomics, and individualized medicine.

Ma Q, Lu AY.

Pharmacol Rev. 2011 Jun;63(2):437-59. doi: 10.1124/pr.110.003533. Review.

13.

The role and impact of SNPs in pharmacogenomics and personalized medicine.

Laing RE, Hess P, Shen Y, Wang J, Hu SX.

Curr Drug Metab. 2011 Jun;12(5):460-86. Review.

PMID:
21453271
14.
15.

[Pharmacogenomics and the path towards personalized medicine].

Belloso WH, Redal MA.

Medicina (B Aires). 2010;70(3):265-74. Review. Spanish.

PMID:
20529779
16.

Pharmacogenomics and active surveillance for serious adverse drug reactions in children.

Loo TT, Ross CJ, Sistonen J, Visscher H, Madadi P, Koren G, Hayden MR, Carleton BC.

Pharmacogenomics. 2010 Sep;11(9):1269-85. doi: 10.2217/pgs.10.111. Review.

PMID:
20860467
17.

How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).

Preskorn SH, Hatt CR.

J Psychiatr Pract. 2013 Mar;19(2):142-9. doi: 10.1097/01.pra.0000428559.01953.73. Review.

PMID:
23507814
18.

Pharmacogenomics and public health: implementing 'populationalized' medicine.

Mette L, Mitropoulos K, Vozikis A, Patrinos GP.

Pharmacogenomics. 2012 May;13(7):803-13. doi: 10.2217/pgs.12.52. Review.

PMID:
22594512
19.

Individualization of drug therapy: history, present state, and opportunities for the future.

Lesko LJ, Schmidt S.

Clin Pharmacol Ther. 2012 Oct;92(4):458-66. doi: 10.1038/clpt.2012.113. Review.

PMID:
22948891
20.

Pharmacogenomics and personalized medicine in clinical practice.

Manolopoulos VG, Dechairo B, Huriez A, Kühn A, Llerena A, van Schaik RH, Yeo KT, Ragia G, Siest G.

Pharmacogenomics. 2011 May;12(5):597-610. doi: 10.2217/pgs.11.14.

PMID:
21619425

Supplemental Content

Support Center